{"id":"intranasal-ibuprofen","safety":{"commonSideEffects":[{"rate":null,"effect":"Nasal irritation"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Rhinitis"},{"rate":null,"effect":"Gastrointestinal upset"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Ibuprofen inhibits cyclooxygenase (COX-1 and COX-2) enzymes, reducing prostaglandin synthesis and thereby decreasing inflammation, pain, and fever. The intranasal formulation allows for rapid absorption through the nasal mucosa, potentially providing faster onset of action compared to oral administration while potentially reducing systemic exposure.","oneSentence":"Intranasal ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) delivered directly to nasal mucosa to reduce inflammation and provide rapid pain relief.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:16:44.120Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute pain management"},{"name":"Migraine headache"}]},"trialDetails":[{"nctId":"NCT06731556","phase":"PHASE3","title":"Analgesic Effects of Intranasal Diclofenac Sodium, Ibuprofen, and Paracetamol in Pediatric Tonsillectomy Cases","status":"COMPLETED","sponsor":"Bezmialem Vakif University","startDate":"2024-12-15","conditions":"Tonsil Disease, Pain Management, Intranasal Drug Administration","enrollment":60},{"nctId":"NCT02985177","phase":"PHASE4","title":"A RCT of a Combination of Analgesics for Pain Management in Children With a Suspected Fracture","status":"WITHDRAWN","sponsor":"St. Justine's Hospital","startDate":"2020-01","conditions":"Emergency Service, Hospital, Child/Adolescent Problem, Acute Pain","enrollment":""},{"nctId":"NCT04444830","phase":"PHASE4","title":"Sprix for Postoperative Pain Control Following Gynecologic Surgery","status":"WITHDRAWN","sponsor":"University of Louisville","startDate":"2021-01","conditions":"Post Operative Pain Control, Narcotic Use, Pelvic Organ Prolapse","enrollment":""},{"nctId":"NCT02521415","phase":"PHASE2","title":"IN Sub-Dissociative Ketamine vs IN Fentanyl","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2015-12","conditions":"Bone Fracture","enrollment":87},{"nctId":"NCT02638506","phase":"PHASE4","title":"RCT Evaluating Intranasal Fentanyl in the Pain Management of Children With Headaches","status":"TERMINATED","sponsor":"St. Justine's Hospital","startDate":"2016-01","conditions":"Headaches","enrollment":62},{"nctId":"NCT02573714","phase":"NA","title":"Sub-dissociative Intranasal Ketamine for Pediatric Sickle Cell Pain Crises","status":"UNKNOWN","sponsor":"Cameroon Baptist Convention Health","startDate":"2015-12","conditions":"Sickle Cell Disease","enrollment":160}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Intranasal Ibuprofen","genericName":"Intranasal Ibuprofen","companyName":"Bezmialem Vakif University","companyId":"bezmialem-vakif-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Intranasal ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) delivered directly to nasal mucosa to reduce inflammation and provide rapid pain relief. Used for Acute pain management, Migraine headache.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}